| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.00029 | 1 |